Detection of Thyroid Cancer and Central Lymph Node Metastases Using EMI-137 Enhanced Molecular Fluorescent Guided Surgery: a Multicentre Feasibility study
Phase of Trial: Phase I
Latest Information Update: 04 Jul 2018
At a glance
- Drugs EMI-137 (Primary)
- Indications Thyroid cancer
- Focus Adverse reactions
- Acronyms TARGET
- 31 Aug 2018 Biomarkers information updated
- 21 Jun 2018 Status changed from not yet recruiting to recruiting.
- 06 Jun 2018 Planned initiation date changed from 1 Apr 2018 to 1 Jul 2018.